Skip to main content
. 2022 Jun 24;22:699. doi: 10.1186/s12885-022-09777-w

Table 3.

Univariate and multivariate analysis of prognostic factors in the cStage III, IVa ESCC treated with NAC

Variable 36 months RFS Univariate p-value 36 months RFS Multivariate p-value
Hazard ratio (95% CI) Hazard ratio (95% CI)
CD20 (high/low) 0.804 (0.442–1.462) 0.4744 1.176 (0.602–2.296) 0.6355
CD8 (high/low) 0.664 (0.342–1.291) 0.2276 0.664 (0.325–1.358) 0.2618
CD23 (high/low) 0.450 (0.219–0.922) 0.0292* 0.437 (0.206–0.924) 0.0302*

RFS Relapse free survival, CI Confidence interval

*p < 0.05, statistically significant